Gálvez J

No ORCID on file · 2 papers in corpus
2026
Exploration of targeted anti-tumor therapy ·doi:10.37349/etat.2026.1002377

Breast cancer classification and therapeutic decision-making have traditionally relied on the evaluation of estrogen receptor alpha (ERα), PR, and HER2, yet this framework does not fully explain tumor heterogeneity, endocrine resistance, or…

other 1979
Revista chilena de obstetricia y ginecologia